Literature DB >> 26857575

XerC Contributes to Diverse Forms of Staphylococcus aureus Infection via agr-Dependent and agr-Independent Pathways.

Danielle N Atwood1, Karen E Beenken1, Allister J Loughran1, Daniel G Meeker1, Tamara L Lantz1, Justin W Graham1, Horace J Spencer2, Mark S Smeltzer3,4,5.   

Abstract

We demonstrate that mutation of xerC, which reportedly encodes a homologue of an Escherichia coli recombinase, limits biofilm formation in the methicillin-resistant Staphylococcus aureus strain LAC and the methicillin-sensitive strain UAMS-1. This was not due to the decreased production of the polysaccharide intracellular adhesin (PIA) in either strain because the amount of PIA was increased in a UAMS-1xerC mutant and undetectable in both LAC and its isogenic xerC mutant. Mutation of xerC also resulted in the increased production of extracellular proteases and nucleases in both LAC and UAMS-1, and limiting the production of either class of enzymes increased biofilm formation in the isogenic xerC mutants. More importantly, the limited capacity to form a biofilm was correlated with increased antibiotic susceptibility in both strains in the context of an established biofilm in vivo. Mutation of xerC also attenuated virulence in a murine bacteremia model, as assessed on the basis of the bacterial loads in internal organs and overall lethality. It also resulted in the decreased accumulation of alpha toxin and the increased accumulation of protein A. These findings suggest that xerC may impact the functional status of agr. This was confirmed by demonstrating the reduced accumulation of RNAIII and AgrA in LAC and UAMS-1xerC mutants. However, this cannot account for the biofilm-deficient phenotype of xerC mutants because mutation of agr did not limit biofilm formation in either strain. These results demonstrate that xerC contributes to biofilm-associated infections and acute bacteremia and that this is likely due to agr-independent and -dependent pathways, respectively.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26857575      PMCID: PMC4807471          DOI: 10.1128/IAI.01462-15

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  63 in total

Review 1.  Biofilm formation: a clinically relevant microbiological process.

Authors:  R M Donlan
Journal:  Clin Infect Dis       Date:  2001-09-20       Impact factor: 9.079

Review 2.  Bacterial biofilms: a common cause of persistent infections.

Authors:  J W Costerton; P S Stewart; E P Greenberg
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

Review 3.  Persister cells in biofilm associated infections.

Authors:  Brian P Conlon; Sarah E Rowe; Kim Lewis
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

4.  Epistatic relationships between sarA and agr in Staphylococcus aureus biofilm formation.

Authors:  Karen E Beenken; Lara N Mrak; Linda M Griffin; Agnieszka K Zielinska; Lindsey N Shaw; Kelly C Rice; Alexander R Horswill; Kenneth W Bayles; Mark S Smeltzer
Journal:  PLoS One       Date:  2010-05-24       Impact factor: 3.240

5.  Periprosthetic joint infection: the economic impact of methicillin-resistant infections.

Authors:  Javad Parvizi; Ian M Pawasarat; Khalid A Azzam; Ashish Joshi; Erik N Hansen; Kevin J Bozic
Journal:  J Arthroplasty       Date:  2010-05-31       Impact factor: 4.757

6.  Staphylococcus aureus ClpYQ plays a minor role in stress survival.

Authors:  Dorte Frees; Line E Thomsen; Hanne Ingmer
Journal:  Arch Microbiol       Date:  2005-04-21       Impact factor: 2.552

7.  Role of the accessory gene regulator (agr) in pathogenesis of staphylococcal osteomyelitis.

Authors:  A F Gillaspy; S G Hickmon; R A Skinner; J R Thomas; C L Nelson; M S Smeltzer
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

8.  A secreted bacterial protease tailors the Staphylococcus aureus virulence repertoire to modulate bone remodeling during osteomyelitis.

Authors:  James E Cassat; Neal D Hammer; J Preston Campbell; Meredith A Benson; Daniel S Perrien; Lara N Mrak; Mark S Smeltzer; Victor J Torres; Eric P Skaar
Journal:  Cell Host Microbe       Date:  2013-06-12       Impact factor: 21.023

9.  Staphylococcus aureus fur regulates the expression of virulence factors that contribute to the pathogenesis of pneumonia.

Authors:  Victor J Torres; Ahmed S Attia; William J Mason; M Indriati Hood; Brian D Corbin; Federico C Beasley; Kelsi L Anderson; Devin L Stauff; W Hayes McDonald; Lisa J Zimmerman; David B Friedman; David E Heinrichs; Paul M Dunman; Eric P Skaar
Journal:  Infect Immun       Date:  2010-01-25       Impact factor: 3.441

10.  Impact of individual extracellular proteases on Staphylococcus aureus biofilm formation in diverse clinical isolates and their isogenic sarA mutants.

Authors:  Allister J Loughran; Danielle N Atwood; Allison C Anthony; Nada S Harik; Horace J Spencer; Karen E Beenken; Mark S Smeltzer
Journal:  Microbiologyopen       Date:  2014-09-25       Impact factor: 3.139

View more
  13 in total

1.  Escherichia coli CFT073 Fitness Factors during Urinary Tract Infection: Identification Using an Ordered Transposon Library.

Authors:  Allyson E Shea; Juan Marzoa; Stephanie D Himpsl; Sara N Smith; Lili Zhao; Lisa Tran; Harry L T Mobley
Journal:  Appl Environ Microbiol       Date:  2020-06-17       Impact factor: 4.792

Review 2.  Targeting fundamental pathways to disrupt Staphylococcus aureus survival: clinical implications of recent discoveries.

Authors:  Isaac P Thomsen; George Y Liu
Journal:  JCI Insight       Date:  2018-03-08

3.  The Increased Accumulation of Staphylococcus aureus Virulence Factors Is Maximized in a purR Mutant by the Increased Production of SarA and Decreased Production of Extracellular Proteases.

Authors:  Duah Alkam; Piroon Jenjaroenpun; Aura M Ramirez; Karen E Beenken; Horace J Spencer; Mark S Smeltzer
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

4.  Functional mgrA Influences Genetic Changes within a Staphylococcus aureus Cell Population over Time.

Authors:  James Lee; Miguel Carda-Diéguez; Miglė Žiemytė; Sarah Vreugde; Clare Cooksley; Heidi A Crosby; Alexander R Horswill; Alex Mira; Peter S Zilm; Stephen P Kidd
Journal:  J Bacteriol       Date:  2022-09-26       Impact factor: 3.476

5.  Global Screening of Salmonella enterica Serovar Typhimurium Genes for Desiccation Survival.

Authors:  Rabindra K Mandal; Young M Kwon
Journal:  Front Microbiol       Date:  2017-09-08       Impact factor: 5.640

6.  Prophages and adaptation of Staphylococcus aureus ST398 to the human clinic.

Authors:  Seydina M Diene; Anna Rita Corvaglia; Patrice François; Nathalie van der Mee-Marquet
Journal:  BMC Genomics       Date:  2017-02-06       Impact factor: 3.969

7.  Suppression of Alternative Lipooligosaccharide Glycosyltransferase Activity by UDP-Galactose Epimerase Enhances Murine Lung Infection and Evasion of Serum IgM.

Authors:  Sandy M Wong; Mary Darby Jackson; Brian J Akerley
Journal:  Front Cell Infect Microbiol       Date:  2019-05-15       Impact factor: 5.293

8.  The Impacts of msaABCR on sarA-Associated Phenotypes Are Different in Divergent Clinical Isolates of Staphylococcus aureus.

Authors:  Joseph S Rom; Aura M Ramirez; Karen E Beenken; Gyan S Sahukhal; Mohamed O Elasri; Mark S Smeltzer
Journal:  Infect Immun       Date:  2020-01-22       Impact factor: 3.441

9.  SarA plays a predominant role in controlling the production of extracellular proteases in the diverse clinical isolates of Staphylococcus aureus LAC and UAMS-1.

Authors:  Aura M Ramirez; Karen E Beenken; Stephanie D Byrum; Alan J Tackett; Lindsey N Shaw; Brittney D Gimza; Mark S Smeltzer
Journal:  Virulence       Date:  2020-12       Impact factor: 5.882

10.  Preliminary study on the effect of brazilin on biofilms of Staphylococcus aureus.

Authors:  Dan Peng; Anlin Chen; Bin Shi; Xun Min; Tao Zhang; Zheling Dong; Huan Yang; Xianlian Chen; Yingbiao Tian; Zehui Chen
Journal:  Exp Ther Med       Date:  2018-07-04       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.